Saturday 17 October 2026
Export CALC’s income statement to Excel — free account
CalciMedica Inc.
CALC Healthcare Biotechnology
In the quarter to June 2026, EPS fell 12.5%, free cash flow grew 31.4% and total debt rose 8.24%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.07
0.01
−0.93%
Follow CALC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(526.36%) | (761.02%) | (399.51%) | (365.70%) | |
| (148.18%) | (177.10%) | (115.11%) | (110.10%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(205.51%) | (301.71%) | (594.95%) | (132.68%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(7.07) | (7.06) | (6.69) | (5.58) | |
Free Cash Flow |
(21.32) | (21.21) | (21.16) | (19.08) | |
Capital Expenditures |
(0.02) | (0.03) | — | 0.02 | |
| Other line items | |||||
Cash ROIC |
(93.86%) | (131.92%) | (153.75%) | (57.25%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(17.72) | (16.26) | (17.18) | (15.16) | |
Operating CF/Net income |
0.92 | 0.72 | 1.08 | 0.90 | |
Depreciation/Fixed assets |
1.12 | 0.92 | 0.88 | 0.86 | |
Capex/Depreciation |
(0.44) | (0.61) | 0.00 | 0.74 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(7.06) | (7.05) | (6.69) | (5.59) | |
Capex per Share |
(0.01) | (0.01) | 0.00 | 0.01 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 |
Columns are period end dates